Intermountain Health logs 2.6% operating margin, $549M net income in Q1 2023

2023-05-22
财报AHA会议
Intermountain Health logs 2.6% operating margin, $549M net income in Q1 2023
Preview
来源: FierceHealthcare
Intermountain Healthcare reported rising volumes and hundreds of millions in investment gains that outpaced the opening months of 2022.
Intermountain Health pulled in $104 million in net operating income (2.6% operating margin) and a $549 million excess of revenues over expenses during the first quarter of 2023, according to recent financial statements from the Rocky Mountain nonprofit.
The 33-hospital system reported a 41.3% year-over-year increase in revenues to nearly $4 billion for the three months ended March 31, though much of the increase can be attributed to last April’s merger with the eight-hospital SCL Health.
Similarly, the system saw a 43.9% year-over-year rise in its operating expenses to $3.7 billion with employee compensation and benefits alone jumping by 51.9%.
Compared to the prior year’s opening quarter (and after interest, depreciation and amortization), Intermountain’s net operating income fell by $26 million.
However, $481 million from investment income during the quarter went a long way to boost its net income to $549 million, particularly compared to the prior year’s $428 million investment loss and resulting $298 million net deficit of revenues over expenses.
Volume numbers accompanying the financials outline an uptick in demand similar to those reported by other systems during the first quarter. When comparing year-over-year data on a pro forma basis that includes pre-merger Intermountain and SCL, inpatient admissions rose 4.3%, adjusted admissions rose 8.2%, emergency room visits rose 3.8% and outpatient visits rose a staggering 30.4% (including joint venture activity).
The system also increased its workforce by 2,570 full-time equivalents compared to legacy head counts, which, alongside industrywide wage increases and economywide inflation, contributed to higher employee compensation and benefits spending at the system.
Intermountain recently closed its year of merger-fueled growth with $121 million in net operating income and a $3.1 billion excess in revenues, though that bottom line was bolstered by almost $4.1 billion in affiliation contributions from the SCL deal. Without those funds on the books, Intermountain’s $1.6 billion in investment losses would have landed the system squarely in the red.
Pitting Intermountain’s latest numbers against those of its large nonprofit peers place the system’s operating performance above Kaiser Permanente’s 0.3% operating margin and Sutter Health’s 2.3% operating margin but still somewhat below Mayo Clinic’s rock-solid 3.5% operating margin. Each of the organizations were well ahead of Catholic giant CommonSpirit Health, which posted a blistering -8% operating margin for the most recent quarter.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。